Alustal Cat Epithelia Extract
Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Patient Information leaflet
(PIL)
28-09-2019
Summary of Product characteristics
(SPC)
27-09-2019
Active ingredient:
Allergen extracts 0.1 IR/mL (Feline epithelium extract); Allergen extracts 1 IR/mL (Feline epithelium extract); Allergen extracts 10 IR/mL (Feline epithelium extract)
Available from:
Stallergenes Greer New Zealand Ltd
INN (International Name):
Allergen extracts 0.1 IR/mL (Feline epithelium extract)
Pharmaceutical form:
Solution for injection
Composition:
Active: Allergen extracts 0.1 IR/mL (Feline epithelium extract) Excipient: Aluminium hydroxide gel Mannitol Phenol Sodium chloride Water Active: Allergen extracts 1 IR/mL (Feline epithelium extract) Excipient: Aluminium hydroxide gel Mannitol Phenol Sodium chloride Water Active: Allergen extracts 10 IR/mL (Feline epithelium extract) Excipient: Aluminium hydroxide gel Mannitol Phenol Sodium chloride Water
Units in package:
Vial, glass, multi-dose, 11mL (5mL fill volume), 5 mL
Class:
Prescription
Prescription type:
Prescription
Manufactured by:
Stallergenes
Product summary:
Package - Contents - Shelf Life: Vial, glass, multi-dose, 11mL (5mL fill volume) - 5 mL - 18 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) 6 months opened stored at 2° to 8°C (Refrigerate, do not freeze)
Authorization date:
2002-05-28
Patient Information leaflet
CONSUMER MEDICINE INFORMATION
Version 10.
1
ALUSTAL®
Page 1 of 7
ALUSTAL®
Pronounced (al-u-stal)
_Contains the active _
_ingredients of different _
_allergens _
_TABLE OF CONTENTS _
_What is in the leaflet.......p.1 _
_What Alustal is used for p.1 _
_Before you are given Alustal _
_........................................p.1 _
_How Alustal is given.......p.2 _
_While you are receiving _
_Alustal............................ p.3 _
_Side effects..................... p.3 _
_After using Alustal.........p.4 _
_Product description.......p.4 _
_Presentation..................p.4 _
_ _
____________________
WHAT IS IN THIS LEAFLET
____________________
This leaflet answers some
common questions about
Alustal allergen extracts.
It does not contain all of the
available information.
It does not take the place of
talking to your doctor or
pharmacist.
All medicines have risks
and benefits. Your doctor
has weighed the risks of
giving you Alustal allergen
extracts against the expected
benefits it will have for you.
IF YOU HAVE ANY CONCERNS
ABOUT BEING GIVEN THIS
MEDICINE, ASK YOUR
DOCTOR OR PHARMACIST.
____________________
WHAT ALUSTAL IS USED FOR
____________________
Alustal belongs to a group
of medicines called
_anti-_
_allergy preparations _
and is
used in the treatment of
seasonal or perennial
rhinitis, conjunctivitis and
rhino-conjunctivitis with or
without associated asthma.
Alustal is given as a
subcutaneous treatment and
this is often referred to as
SIT (Subcutaneous
Immunotherapy Treatment)
_HOW IT WORKS: _
_ _
A list of allergen available
in Australia and New
Zeeland is provided at the
end of this leaflet. . The
exact type will depend on
your allergy and what your
doctor identifies as the
cause of your allergy. The
aim of treatment with
allergen extracts is to
prevent the more severe
allergic reactions you
experience.
Alustal works by slowly
increasing your tolerance to
specific allergens and
decreases the severity of
your allergic reactions.
The injection is specifically
designed according to
individual patient needs.
Read the complete document
Summary of Product characteristics
NEW ZEALAND DATA SHEET
Version 2.5
Page 1 of 13
1 PRODUCT NAME
ALUSTAL – SINGLE ALLERGENS
ALUSTAL – DISPENSED MIXTURES
A range of various ALUSTAL allergen extracts are registered in New
Zealand either as a single
allergen extract or combination allergen extracts. These include mite
extracts, pollen extracts and
animal extracts.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ALUSTAL is prepared from freeze-dried allergen extracts adsorbed onto
aluminium hydroxide gel.
The freeze-dried allergen extracts are prepared by ammonium
bicarbonate extraction of the allergen
source materials e.g. pollen, mites. Specific allergen(s) are selected
by the physician for Specific
Immunotherapy Treatment (SIT) for the individual patient.
Each 5mL vial contains specific allergen extract(s) in suspension and
are available in various
concentrations. Different concentrations are identified by different
coloured caps on the vials.
YELLOW CAP: 0.1 IR/ML
OR
0.1 IC/ML
GREEN CAP:
1.0 IR/ML
OR
1.0 IC/ML
BLUE CAP:
10.0 IR/ML
OR
10.0 IC/ML
IR (Index of Reactivity): An allergen extract is said to have a titre
of 100 IR/mL if in a prick-test
performed using a Stallerpoint
in 30 subjects sensitised to the allergen in question, it produces a
wheal measuring 7 mm in diameter (geometric mean). Skin reactivity in
these subjects is
simultaneously demonstrated by a positive response to a prick-test
with codeine phosphate 9% or
histamine dihydrochloride 10 mg/mL.
IC (Index of Concentration): An allergen extract has an Index of
Concentration of 100 IC/mL when
its manufacturing parameters lead to the same dilution ratio as those
of standardized extracts at 100
IR/mL from the same family, taken as a reference.
When the family does not contain any standardized reference extract,
the value 100 IC/mL
corresponds to an extract where the dilution ratio is established
according to medical experience.
For the full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Suspension for injection
4 CLINICAL PARTICULARS
4.1
Therapeutic indications
ALUS
Read the complete document
